{"DataElement":{"publicId":"2234841","version":"1","preferredName":"Hormone Therapy Current Administered Type","preferredDefinition":"the type of current hormone therapy administered.","longName":"HORM_CUR_ADM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2234838","version":"1","preferredName":"Hormone Therapy Current Administered","preferredDefinition":"information related to the current hormone therapy being administered.","longName":"HORMTX_CUR_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2433915","version":"1","preferredName":"Hormone Therapy","preferredDefinition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.","longName":"C15445","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06674CCB-CDA8-04A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207813","version":"1","preferredName":"Current Administered","preferredDefinition":"Occurring in or belonging to the present time.:Given.","longName":"C25471:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Current","conceptCode":"C25471","definition":"Occurring in or belonging to the present time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3149-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-727A-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2234814","version":"1","preferredName":"Hormone Therapy Type","preferredDefinition":"the type of hormone therapy.","longName":"HORMONETX_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"LHRH alone","valueDescription":"LHRH alone","ValueMeaning":{"publicId":"2575347","version":"1","preferredName":"LHRH alone","longName":"2575347","preferredDefinition":"LHRH alone","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F360-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F970CDF6-F927-21D3-E034-0003BA3F9857","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2005-06-14","deletedIndicator":"No"},{"value":"LHRH + antiandrogen","valueDescription":"LHRH + antiandrogen","ValueMeaning":{"publicId":"2575356","version":"1","preferredName":"LHRH + antiandrogen","longName":"2575356","preferredDefinition":"LHRH + antiandrogen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F369-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9875C66-0797-1634-E034-0003BA3F9857","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","deletedIndicator":"No"},{"value":"Orchiectomy alone","valueDescription":"Orchiectomy alone","ValueMeaning":{"publicId":"2575357","version":"1","preferredName":"Orchiectomy alone","longName":"2575357","preferredDefinition":"Orchiectomy alone","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F36A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F986A835-AEF0-1562-E034-0003BA3F9857","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","deletedIndicator":"No"},{"value":"Orchiectomy + antiandrogen","valueDescription":"Orchiectomy + antiandrogen","ValueMeaning":{"publicId":"2575360","version":"1","preferredName":"Orchiectomy + antiandrogen","longName":"2575360","preferredDefinition":"Orchiectomy + antiandrogen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F36D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F986A835-AEF4-1562-E034-0003BA3F9857","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","deletedIndicator":"No"},{"value":"LHRH agonist alone","valueDescription":"LHRH agonist alone","ValueMeaning":{"publicId":"2575358","version":"1","preferredName":"LHRH agonist alone","longName":"2575358","preferredDefinition":"LHRH agonist alone","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F36B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F986A835-AEF8-1562-E034-0003BA3F9857","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","deletedIndicator":"No"},{"value":"LHRH agonist + antiandrogen","valueDescription":"LHRH agonist + antiandrogen","ValueMeaning":{"publicId":"2575359","version":"1","preferredName":"LHRH agonist + antiandrogen","longName":"2575359","preferredDefinition":"LHRH agonist + antiandrogen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F36C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F986A835-AEFC-1562-E034-0003BA3F9857","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","deletedIndicator":"No"},{"value":"Estrogen Replacement","valueDescription":"Estrogen Replacement","ValueMeaning":{"publicId":"2583863","version":"1","preferredName":"Estrogen Replacement","longName":"2583863","preferredDefinition":"Administration of an estrogen to treat estrogen deficiency, as that following menopause; in women with a uterus, a progestational agent is usually included to prevent endometrial hyperplasia (Copyright ? 2006 Farlex, Inc.)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25B0510B-E047-24A2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25B0510B-E05E-24A2-E044-0003BA3F9857","beginDate":"2006-12-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-12-28","modifiedBy":"ONEDATA","dateModified":"2006-12-28","deletedIndicator":"No"},{"value":"LHRH agonist","valueDescription":"LHRH agonist","ValueMeaning":{"publicId":"2573099","version":"1","preferredName":"LHRH agonist","longName":"2573099","preferredDefinition":"A synthetic analogue of the endogenous hormone gonadotropin-releasing hormone (GnRH), with potential antineoplastic activity. Upon administration, GnRH analogue mimics endogenous GnRH and strongly binds to and activates pituitary GnRH receptors, which stimulates the synthesis and secretion of the gonadotropic hormones, follicle stimulating hormone (FSH) and luteinizing hormone (LH). Continuous, prolonged activation by the GnRH analogue results in pituitary GnRH receptor desensitization and receptor downregulation. This causes inhibition of pituitary gonadotropin secretion of LH and FSH. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen after castration. This may inhibit androgen receptor-positive tumor progression. In females, this results in a decrease in estradiol production. GnRH, also called luteinizing hormone-releasing hormone (LH-RH), is normally synthesized in and secreted by the hypothalamus. Synthetic analogues of GnRH have a stronger receptor binding affinity than the endogenous form.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gonadotropin-releasing Hormone Analog","conceptCode":"C1910","definition":"A synthetic analogue of the endogenous hormone gonadotropin-releasing hormone (GnRH), with potential antineoplastic activity. Upon administration, GnRH analogue mimics endogenous GnRH and strongly binds to and activates pituitary GnRH receptors, which stimulates the synthesis and secretion of the gonadotropic hormones, follicle stimulating hormone (FSH) and luteinizing hormone (LH). Continuous, prolonged activation by the GnRH analogue results in pituitary GnRH receptor desensitization and receptor downregulation. This causes inhibition of pituitary gonadotropin secretion of LH and FSH. In males, the inhibition of LH secretion prevents the production and release of testosterone from Leydig cells in the testes and causes a significant decline in testosterone production that is near the levels seen after castration. This may inhibit androgen receptor-positive tumor progression. In females, this results in a decrease in estradiol production. GnRH, also called luteinizing hormone-releasing hormone (LH-RH), is normally synthesized in and secreted by the hypothalamus. Synthetic analogues of GnRH have a stronger receptor binding affinity than the endogenous form.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA98-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-02-08","modifiedBy":"COOPERM","dateModified":"2016-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25B057DB-8E0C-21FB-E044-0003BA3F9857","beginDate":"2006-12-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-12-28","modifiedBy":"ONEDATA","dateModified":"2006-12-28","deletedIndicator":"No"},{"value":"Contraception","valueDescription":"Contraception","ValueMeaning":{"publicId":"2576540","version":"1","preferredName":"Contraception","longName":"2576540","preferredDefinition":"The prevention of conception or impregnation by the use of devices or drugs or surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contraception","conceptCode":"C37932","definition":"The prevention of conception or impregnation by the use of devices or drugs or surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F809-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-12","modifiedBy":"REEVESD","dateModified":"2007-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"37233A3C-F823-585D-E050-BB89AD43634F","beginDate":"2016-07-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-07-08","modifiedBy":"ONEDATA","dateModified":"2016-07-08","deletedIndicator":"No"},{"value":"Postmenopausal","valueDescription":"Postmenopausal","ValueMeaning":{"publicId":"3304903","version":"1","preferredName":"Postmenopausal","longName":"3304903","preferredDefinition":"Refers to the time after menopause. Menopause is the time in a woman's life when menstrual periods stop permanently; also called \"change of life.\"","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Postmenopausal","conceptCode":"C15421","definition":"After menopause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1F082AF-4C8A-084F-E040-BB89AD43446D","latestVersionIndicator":"Yes","beginDate":"2011-11-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-11-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"37233A3C-F82E-585D-E050-BB89AD43634F","beginDate":"2016-07-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-07-08","modifiedBy":"ONEDATA","dateModified":"2016-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F910-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"CAMPBELB","dateModified":"2016-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4528054","version":"1","longName":"NWU2013-01-03","context":"DCP"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Current hormone therapy type","type":"Preferred Question Text","description":"Current hormone therapy type","url":null,"context":"CTEP"},{"name":"Template Text","type":"Alternate Question Text","description":"Hormone Therapy Type","url":null,"context":"CTEP"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"What type of hormone treatment is the participant using?  Be sure to complete a ConMeds form.","url":null,"context":"DCP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F9868260-C45C-1564-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"LISU","dateModified":"2020-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}